Biopsafe ApS: Financial statements 2018
CVR: 33575505
Source: annual report 2018, Danish Business Authority
01/04/2017 – 31/03/2018
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 4,578,003 and a net result of DKK 38,863 compared with DKK -2,230,859 the year before. That is an increase of 721.4% compared with the year before. Equity in the 2018 report amounted to DKK 3,475,303. The solvency ratio was 12%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 4,578,003
- Profit/Loss
- DKK 38,863
- Equity
- DKK 3,475,303
- Total Assets
- DKK 28,860,595
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 4.6 mio. | 39 t. | 3.5 mio. | 1 |
| 2017 | - | 557 t. | -2.2 mio. | 436 t. | 1 |
| 2016 | - | 1.9 mio. | 27 t. | 167 t. | - |
| 2015 | - | 266 t. | -1 mio. | 140 t. | - |
| 2014 | - | -2 | -222 t. | 111 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
On September 7, 2018, the company changed its name from AX-LAB INNOVATION ApS to Biopsafe ApS.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.